Skip to content

Clinical study of meta-injection precision optimization of infectious shock cycle function

Clinical study of meta-injection precision optimization of infectious shock cycle function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005614
Enrollment
Unknown
Registered
2022-02-07
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious shock

Interventions

Control group:Guide treatment
Treatment group:Participation injecting

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.the age is between 18 and 80 years old,male or female.2.Compliance with infectious shock diagnostic criteria, on the basis of sepsis, there is a continuous low blood pressure, and vascular active drugs are still needed after full capacity recovery to maintain average arterial pressure (MAP) = 65mmHg, and blood lactate concentration>2mmol/L.3.Check at the ICU within 24 hours.4. No vascular active drugs are used when admission.5. voluntarily signed an informed consent.

Exclusion criteria

Exclusion criteria: 1. acute cerebrovascular disease, malignant tumor.2.Pregnancy or lactating women.3.Drug allergies during medication.4.The efficacy or safety judgment is not judged by specified medication.5.Heartborne shock, blood loss shock, obstructive shock, caused by other reasons.6.Other clinical trials have participated in other clinical trials over the past three months

Design outcomes

Primary

MeasureTime frame
Vascular active drug use time;

Secondary

MeasureTime frame
28 days sorrow rate;Liver and kidney function;Hemodynamic index;Liquid balance before a week;Liver and kidney function;Lac;Coagulation function;ICU hospital stay;Inflammatory factor level;Adverse reactions;Mechanical ventilation time;

Countries

China

Contacts

Public ContactJiayan Sun
451741426@qq.com18051061014

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026